等待開盤 08-14 09:30:00 美东时间
-0.030
-0.39%
- EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia -- European CTA
08-07 19:42
据知情人士透露,艾伯维正在洽谈收购专注于精神健康治疗的Gilgamesh Pharmaceuticals。如果交易成功,将增强艾伯维在精神疾病治疗方面的产品管线。
07-31 08:52
An announcement from Cybin ( ($TSE:CYBN) ) is now available. Cybin has received...
07-17 20:10
https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests
07-16 22:45
Cybin ( ($TSE:CYBN) ) just unveiled an update. On July 14, 2025, Cybin Inc. fil...
07-15 05:47
Canaccord Genuity analyst Sumant Kulkarni maintains Cybin (AMEX:CYBN) with a Buy and lowers the price target from $73 to $70.
07-09 01:27
Cybin, Inc. ( ($CYBN) ) has released its Q4 earnings. Here is a breakdown of th...
07-08 11:50
Cybin press release (NYSE:CYBN): Q4 Cash totaled C$135 million as of March 31, 2025. Net loss was C$31 million for the quarter ended March 31, 2025, compared to a net loss of C$21 million in the same ...
07-01 14:23
https://www.bloomberg.com/news/articles/2025-06-30/colorado-moves-to-allow-hallucinogen-ibogaine-for-medical-use?embedded-checkout=true
06-30 23:58
https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-military-veterans-within-12-months/
06-25 01:44